» Articles » PMID: 31269909

Association of Sarcopenic Obesity with the Risk of All-cause Mortality Among Adults over a Broad Range of Different Settings: a Updated Meta-analysis

Overview
Journal BMC Geriatr
Publisher Biomed Central
Specialty Geriatrics
Date 2019 Jul 5
PMID 31269909
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous cohort studies investigating the association between sarcopenic obesity (SO) and all-cause mortality among adult people have been inconsistent. We performed a meta-analysis to determine if SO is a predictor of all-cause mortality.

Methods: Prospective cohort studies that evaluated the association between SO and mortality in older people were identified via a systematic search of three electronic databases (PubMed, EMBASE, and the Cochrane Library). A random-effects model was applied to combine the results. We considered the methods recommeded by consensuses (dual X-ray absorptiometry,bio-impedancemetry, anthropometric measures or CT scan) to assess sarcopenic obesity.

Results: Of the 603 studies identified through the systematic review, 23 (Participants: 50866) were included in the meta-analysis. The mean age ranged from 50 to 82.5 years.SO was significantly associated with a higher risk of all-cause mortality among adult people (pooled HR = 1.21, 95% confidence interval [95% CI] = 1.10-1.32, p < 0.001, I = 64.3%). Furthermore, the subgroup analysis of participants showed that SO was associated with all-cause mortality (pooled HR = 1.14, 95% CI: 1.06-1.23) among community-dwelling adult people; similarly, this association was found in hospitalized patients (pooled HR = 1.65, 95% CI: 1.17-2.33). Moreover, the subgroup analysis demonstrated that SO was associated with all-cause mortality when using skeletal muscle mass (SMM) criteria, muscle strength criteria, and skeletal muscle index (SMI) criteria (HR = 1.12, 95% CI: 1.01-1.23; HR = 1.18, 95% CI: 1.05-1.33; and HR = 1.53, 95% CI: 1.13-2.07, respectively). In addition, we analyzed SO on the basis of obesity definition and demonstrated that participants with a SO diagnosis based on waist circumference (WC) (HR = 1.24, 95% CI: 1.09-1.40), body mass index (BMI) (HR = 1.29, 95% CI: 1.04-1.59), or visceral fat area (HR = 2.54, 95% CI: 1.83-3.53) have a significantly increase mortality risk compared with those without SO.

Conclusion: Based on our update of existing scientific researches, SO is a significant predictor of all-cause mortality among older people, particularly hospitalized patients. Therefore, it is important to diagnose SO and to treat the condition to reduce mortality rates among older people.

Citing Articles

Sarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women.

Park J, Chung Y, Song J, Kil K, Lee H, Chae J J Menopausal Med. 2025; 30(3):143-151.

PMID: 39829191 PMC: 11745730. DOI: 10.6118/jmm.24004.


Can simple measures from clinical practice serve as a proxy for sarcopenic obesity and identify mortality risk?.

Guandalini V, Tofani P, Souza Lima S, Coelho Silveira L, Cochar-Soares N, Barros Pereira da Silva T Aging Clin Exp Res. 2024; 36(1):222.

PMID: 39557762 PMC: 11573834. DOI: 10.1007/s40520-024-02866-9.


Acute Sarcopenia: Mechanisms and Management.

Damanti S, Senini E, De Lorenzo R, Merolla A, Santoro S, Festorazzi C Nutrients. 2024; 16(20).

PMID: 39458423 PMC: 11510680. DOI: 10.3390/nu16203428.


The Oldest of Old Male C57B/6J Mice Are Protected from Sarcopenic Obesity: The Possible Role of Skeletal Muscle Protein Kinase B Expression.

Reynolds 4th T, Mills N, Hoyte D, Ehnstrom K, Arata A Int J Mol Sci. 2024; 25(19).

PMID: 39408607 PMC: 11476861. DOI: 10.3390/ijms251910278.


The Performance and Associated Risks of the Criteria for Sarcopenic Obesity Proposed by the European Association for the Study of Obesity in a Geriatric Population.

Molina-Baena B, Alvarez-Bustos A, Antonio Carnicero J, Garcia-Garcia F, Rodriguez-Manas L Nutrients. 2024; 16(19).

PMID: 39408282 PMC: 11478913. DOI: 10.3390/nu16193315.


References
1.
Gariballa S, Alessa A . Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr. 2013; 32(5):772-6. DOI: 10.1016/j.clnu.2013.01.010. View

2.
Pecorelli N, Carrara G, De Cobelli F, Cristel G, Damascelli A, Balzano G . Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg. 2016; 103(4):434-42. DOI: 10.1002/bjs.10063. View

3.
Steihaug O, Gjesdal C, Bogen B, Kristoffersen M, Lien G, Ranhoff A . Sarcopenia in patients with hip fracture: A multicenter cross-sectional study. PLoS One. 2017; 12(9):e0184780. PMC: 5597226. DOI: 10.1371/journal.pone.0184780. View

4.
Itoh S, Yoshizumi T, Kimura K, Okabe H, Harimoto N, Ikegami T . Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma. Anticancer Res. 2016; 36(6):3029-34. View

5.
Cawthon P, Lui L, Taylor B, McCulloch C, Cauley J, Lapidus J . Clinical Definitions of Sarcopenia and Risk of Hospitalization in Community-Dwelling Older Men: The Osteoporotic Fractures in Men Study. J Gerontol A Biol Sci Med Sci. 2017; 72(10):1383-1389. PMC: 5861971. DOI: 10.1093/gerona/glw327. View